Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;70(6):1691-703.
doi: 10.1093/jac/dkv010. Epub 2015 Feb 4.

Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase

Affiliations

Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase

Juan D Guzman et al. J Antimicrob Chemother. 2015.

Abstract

Objectives: (S)-Leucoxine, isolated from the Colombian Lauraceae tree Rhodostemonodaphne crenaticupula Madriñan, was found to inhibit the growth of Mycobacterium tuberculosis H37Rv. A biomimetic approach for the chemical synthesis of a wide array of 1-substituted tetrahydroisoquinolines was undertaken with the aim of elucidating a common pharmacophore for these compounds with novel mode(s) of anti-TB action.

Methods: Biomimetic Pictet-Spengler or Bischler-Napieralski synthetic routes were employed followed by an evaluation of the biological activity of the synthesized compounds.

Results: In this work, the synthesized tetrahydroisoquinolines were found to inhibit the growth of M. tuberculosis H37Rv and affect its whole-cell phenotype as well as the activity of the ATP-dependent MurE ligase, a key enzyme involved in the early stage of cell wall peptidoglycan biosynthesis.

Conclusions: As the correlation between the MIC and the half-inhibitory enzymatic concentration was not particularly strong, there is a credible possibility that these compounds have pleiotropic mechanism(s) of action in M. tuberculosis.

Keywords: Mycobacterium tuberculosis; SPOTi; TB; aporphine alkaloids; cell wall peptidoglycan; drug resistance; tuberculosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Bischler–Napieralski-mediated synthesis to ortho-cyclized THIs 3640. (a) NCS or NIS, CH2Cl2; 85% and 81% yield, respectively; (b) For X = Cl and I, B2H6.SMe2, 42% and 55%, respectively. (c) Br2, CH3CO2H, 67%. (d) 3,4-(Methylenedioxy)phenylethanoic acid, N,N-dicyclohexylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP), CH2Cl2; X = Cl and X = Br, 99%, X = I, 74%. (e) POCl3, toluene, reflux. (f) NaBH3CN, MeOH; 36 19%, 37 19%, 38 2% over two steps. (g) 36, NBS, CH2Cl2, 35%. (h) 37, LiAlH4, –78°C, 89%.
Figure 2.
Figure 2.
Chemical structures of the natural aporphines 3-methoxynordomesticine and (S)-leucoxine (1) and the synthetic THIs 2-40. Compounds 1-40 were evaluated in this study.
Figure 3.
Figure 3.
Comparison of the three-dimensional surface of four active alkaloids using FieldTemplater (Cresset software). Alignment of 3-methoxynordomesticine, leucoxine (1), 28 and 35 showing surfaces of different chemical environments. Turquoise surfaces represent negative patches, red surfaces correspond to positive sections, brick yellow surfaces denote lipophilic regions and light yellow volumes relate to dominant van der Waals areas. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Figure 4.
Figure 4.
Acid fast staining of M. bovis BCG after 48 h of treatment with d-cycloserine (DCS) and 39, and comparison of the cell length. (a) Control with DMSO. (b) DCS at 100 mg/L. (c) Compound 39 at 160 mg/L. Magnification ×1000. (d) The cell length of M. bovis BCG after treatment with vehicle (DMSO), DCS (100 mg/L) and 39 (160 mg/L). The dots represent the raw data and the diamonds represent the mean value with SD (error bars). The cell length of 100 cells was manually measured for each treatment from microscopic images. The mean cell sizes of the three treatments were statistically significant at P < 0.01. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.

Similar articles

Cited by

References

    1. WHO. Global Tuberculosis Report 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf.
    1. Loewenberg S. India reports cases of totally drug-resistant tuberculosis. Lancet 2012; 379: 205. - PubMed
    1. Gandhi NR, Shah NS, Andrews JR, et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Resp Critical Care Med 2010; 181: 80–6. - PubMed
    1. Kishore N, Mishra BB, Tripathi V, et al. Alkaloids as potential anti-tubercular agents. Fitoterapia 2009; 80: 149–63. - PubMed
    1. Song F, Liu X, Guo H, et al. Brevianamides with antitubercular potential from a marine-derived isolate of Aspergillus versicolor. Org Lett 2012; 14: 4770–3. - PubMed

Publication types

MeSH terms